Cargando…

Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial

BACKGROUND: Calcium release-activated calcium (CRAC) channel inhibitors stabilize the pulmonary endothelium and block proinflammatory cytokine release, potentially mitigating respiratory complications observed in patients with COVID-19. This study aimed to investigate the safety and efficacy of Auxo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Joseph, Bruen, Charles, Schnaus, Michael, Zhang, Jeffrey, Ali, Sadia, Lind, April, Stoecker, Zachary, Stauderman, Kenneth, Hebbar, Sudarshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427272/ https://www.ncbi.nlm.nih.gov/pubmed/32795330 http://dx.doi.org/10.1186/s13054-020-03220-x

Ejemplares similares

Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial
por: Bruen, Charles, et al.
Publicado: (2022)

Auxora for the Treatment of Patients With Acute Pancreatitis and Accompanying Systemic Inflammatory Response Syndrome: Clinical Development of a Calcium Release-Activated Calcium Channel Inhibitor
por: Bruen, Charles, et al.
Publicado: (2021)

Handbook on loss reserving
por: Radtke, Michael, et al.
Publicado: (2016)

Orai1 calcium channel inhibition prevents progression of chronic pancreatitis
por: Szabó, Viktória, et al.
Publicado: (2023)

A Store-operated Calcium Channel in Drosophila S2 Cells
por: Yeromin, Andriy V., et al.
Publicado: (2004)

Laparoscopic Drainage of a Hepatic Echinococcal Cyst: A Case Report
por: Goldin, Steven B., et al.
Publicado: (2011)

VARIATION OF BASAL METABOLIC RATE PER UNIT SURFACE AREA WITH AGE
por: Bruen, Curtis
Publicado: (1930)

Treatment of Ulcers by Circumcision
por: Bruen, E. T.
Publicado: (1873)

Some Observations on the Carlsbad Treatment
por: Bruen, E. T.
Publicado: (1881)

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
por: Cardona-Pascual, Ignacio, et al.
Publicado: (2022)

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
por: Cardona-Pascual, Ignacio, et al.
Publicado: (2022)

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
por: Aomar-Millán, Ismael F., et al.
Publicado: (2022)

Beneficial of adding Tocilizumab to standard care in critical forms of Covid-19 pneumonia: Study on paired series
por: Trif, Ahlem, et al.
Publicado: (2022)

Shooting from the ‘Scrip: Scope of Practice Laws and Access to Immunizations in the Pharmacy Setting
por: Stoecker, Charles
Publicado: (2021)

WHOIS running the Internet: protocol, policy, and privacy
por: Bruen, Garth O
Publicado: (2015)

Pneumonia panel results and antibiotic prescribing in COVID-19 patients in 2020 versus 2022
por: Hussain, Aysha, et al.
Publicado: (2023)

A critical look at challenges and future scopes of bioactive compounds and their incorporations in the food, energy, and pharmaceutical sector
por: Pai, Sanidhya, et al.
Publicado: (2022)

Ceftazidime–Avibactam-Based Versus Tigecycline-Based Regimen for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae-Induced Pneumonia in Critically Ill Patients
por: Shi, Ying, et al.
Publicado: (2021)

Podcast on the Art of the Patient Conversation: Healthcare Provider Perspectives to Improve Outcomes in Multiple Sclerosis
por: Roman, Cortnee, et al.
Publicado: (2023)

Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Comparison of the Respiratory Resistomes and Microbiota in Children Receiving Short versus Standard Course Treatment for Community-Acquired Pneumonia
por: Pettigrew, M. M., et al.
Publicado: (2022)

Manifestations and complications of Mycoplasma pneumoniae disease: a review.
por: Lind, K.
Publicado: (1983)

Vitamin D deficiency in pediatric critical illness()
por: Hebbar, Kiran B., et al.
Publicado: (2014)

Anchoring on COVID-19: A Case Report of Human Granulocytic Anaplasmosis Masquerading as COVID-19
por: Stice, Mark J., et al.
Publicado: (2021)

Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care
por: Quartuccio, Luca, et al.
Publicado: (2020)

Diabetes-Specific Formulae Versus Standard Formulae as Enteral Nutrition to Treat Hyperglycemia in Critically Ill Patients: Protocol for a Randomized Controlled Feasibility Trial
por: Doola, Ra'eesa, et al.
Publicado: (2018)

Peptide-based formula versus standard-based polymeric formula for critically ill children: is it superior for patients’ tolerance?
por: Ibrahim, Hanan, et al.
Publicado: (2020)

Judging the Data: Peer Review versus Good Laboratory Practice Standards
por: Schmidt, Charles W.
Publicado: (2012)

Nosocomial pneumonia in critically ill patients
por: Dandagi, Girish L.
Publicado: (2010)

Pneumonia: Considerations for the Critically Ill Patient
por: Niederman, Michael S.
Publicado: (2008)

Outcomes associated with tocilizumab with or without corticosteroid versus dexamethasone for treatment of patients with severe to critical COVID-19 pneumonia
por: AlQahtani, Hajar, et al.
Publicado: (2022)

Extra Physiotherapy in Critical Care (EPICC) Trial Protocol: a randomised controlled trial of intensive versus standard physical rehabilitation therapy in the critically ill
por: Thomas, Kirsty, et al.
Publicado: (2015)

Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis
por: Lecronier, Marie, et al.
Publicado: (2020)

Meropenem-Resistant Pandoraea Pneumonia in a Critically Ill Patient With COVID-19
por: Dlewati, Mohammad M, et al.
Publicado: (2021)

Comparison of high-flow nasal oxygen cannula therapy versus a standard oxygen face mask in patients with hypostatic pneumonia
por: Song, Yamei, et al.
Publicado: (2021)

miR-155 in the Resolution of Atherosclerosis
por: Bruen, Robyn, et al.
Publicado: (2019)

Treatment of COVID-19 pneumonia with low-dose radiotherapy plus standard of care versus standard of care alone in frail patients: The SEOR-GICOR IPACOVID comparative cohort trial
por: Arenas, M., et al.
Publicado: (2023)

Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19
por: Hamilton, David Oliver, et al.
Publicado: (2021)

Continuous Versus Routine Standardized Electroencephalogram for Outcome Prediction in Critically Ill Adults: Analysis From a Randomized Trial
por: Beuchat, Isabelle, et al.
Publicado: (2021)

Factors Predictive of Ventilator-associated Pneumonia in Critically Ill Trauma Patients
por: Younan, Duraid, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t7qih99epbt0s0s5ikjb97rap6